453 related articles for article (PubMed ID: 33605203)
1. Feasibility of Convalescent Plasma Therapy in Kidney Transplant Recipients With Severe COVID-19: A Single-Center Prospective Cohort Study.
Gupta A; Kute VB; Patel HV; Engineer DP; Banerjee S; Modi PR; Rizvi SJ; Mishra VV; Patel AH; Navadiya V
Exp Clin Transplant; 2021 Apr; 19(4):304-309. PubMed ID: 33605203
[TBL] [Abstract][Full Text] [Related]
2. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P
Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856
[TBL] [Abstract][Full Text] [Related]
3. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
4. Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy.
Naeem S; Gohh R; Bayliss G; Cosgrove C; Farmakiotis D; Merhi B; Morrissey P; Osband A; Bailey JA; Sweeney J; Rogers R
Transpl Infect Dis; 2021 Feb; 23(1):e13451. PubMed ID: 32815238
[TBL] [Abstract][Full Text] [Related]
5. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
6. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
8. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
9. A Narrative Review COVID-19 in Solid-Organ Transplantation: Real-World Evidence From India.
Kute VB; Rela M; Abraham G; Gulati S; Bhalla AK; Chauhan S; Mishra VV; Meshram HS
Exp Clin Transplant; 2022 Aug; 20(Suppl 4):32-42. PubMed ID: 36018018
[TBL] [Abstract][Full Text] [Related]
10. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
12. Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.
Bayrak M; Çadirci K
Pan Afr Med J; 2021; 38():273. PubMed ID: 34122700
[TBL] [Abstract][Full Text] [Related]
13. Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions.
Mahapatra S; Rattan R; Mohanty CBK
Transfus Clin Biol; 2021 Aug; 28(3):246-253. PubMed ID: 33965621
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
Demir E; Uyar M; Parmaksiz E; Sinangil A; Yelken B; Dirim AB; Merhametsiz O; Yadigar S; Atan Ucar Z; Ucar AR; Demir ME; Mese M; Akin EB; Garayeva N; Safak S; Oto OA; Yazici H; Turkmen A
Transpl Infect Dis; 2020 Oct; 22(5):e13371. PubMed ID: 32657540
[TBL] [Abstract][Full Text] [Related]
15. Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
Joyner MJ; Wright RS; Fairweather D; Senefeld JW; Bruno KA; Klassen SA; Carter RE; Klompas AM; Wiggins CC; Shepherd JR; Rea RF; Whelan ER; Clayburn AJ; Spiegel MR; Johnson PW; Lesser ER; Baker SE; Larson KF; Ripoll JG; Andersen KJ; Hodge DO; Kunze KL; Buras MR; Vogt MN; Herasevich V; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Van Buskirk CM; Winters JL; Stubbs JR; Paneth NS; Verdun NC; Marks P; Casadevall A
J Clin Invest; 2020 Sep; 130(9):4791-4797. PubMed ID: 32525844
[TBL] [Abstract][Full Text] [Related]
16. Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City.
Rahman F; Liu STH; Taimur S; Jacobs S; Sullivan T; Dunn D; Baneman E; Fuller R; Aberg JA; Bouvier N; Rana MM
Clin Transplant; 2020 Dec; 34(12):e14089. PubMed ID: 32918761
[TBL] [Abstract][Full Text] [Related]
17. Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial).
van den Berg K; Glatt TN; Vermeulen M; Little F; Swanevelder R; Barrett C; Court R; Bremer M; Nyoni C; Swarts A; Mmenu C; Crede T; Kritzinger G; Naude J; Szymanski P; Cowley J; Moyo-Gwete T; Moore PL; Black J; Singh J; Bhiman JN; Baijnath P; Mody P; Malherbe J; Potgieter S; van Vuuren C; Maasdorp S; Wilkinson RJ; Louw VJ; Wasserman S
Sci Rep; 2022 Feb; 12(1):2552. PubMed ID: 35169169
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
O'Donnell MR; Grinsztejn B; Cummings MJ; Justman JE; Lamb MR; Eckhardt CM; Philip NM; Cheung YK; Gupta V; João E; Pilotto JH; Diniz MP; Cardoso SW; Abrams D; Rajagopalan KN; Borden SE; Wolf A; Sidi LC; Vizzoni A; Veloso VG; Bitan ZC; Scotto DE; Meyer BJ; Jacobson SD; Kantor A; Mishra N; Chauhan LV; Stone EF; Dei Zotti F; La Carpia F; Hudson KE; Ferrara SA; Schwartz J; Stotler BA; Lin WW; Wontakal SN; Shaz B; Briese T; Hod EA; Spitalnik SL; Eisenberger A; Lipkin WI
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33974559
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
Huang S; Shen C; Xia C; Huang X; Fu Y; Tian L
Med Sci Monit; 2020 Dec; 26():e928755. PubMed ID: 33264276
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 pneumonia in kidney transplant recipients: A promising treatment algorithm in the absence of a disease-specific drug.
Karatas M; Tatar E; Simsek C; Yıldırım AM; Ari A; Zengel B; Uslu A
J Med Virol; 2021 Oct; 93(10):5789-5797. PubMed ID: 34050953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
